SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-143760
Filing Date
2023-05-15
Accepted
2023-05-12 21:14:00
Documents
14
Period of Report
2023-05-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d485812d8k.htm   iXBRL 8-K 26167
2 EX-99.1 d485812dex991.htm EX-99.1 7672
6 GRAPHIC g485812g45i94.jpg GRAPHIC 7456
  Complete submission text file 0001193125-23-143760.txt   165620

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ctlt-20230512.xsd EX-101.SCH 2841
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctlt-20230512_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctlt-20230512_pre.xml EX-101.PRE 10806
8 EXTRACTED XBRL INSTANCE DOCUMENT d485812d8k_htm.xml XML 3216
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent, Inc. (Filer) CIK: 0001596783 (see all company filings)

IRS No.: 208737688 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36587 | Film No.: 23917980
SIC: 2834 Pharmaceutical Preparations